In infected COVID-19 patients, serum luteinizing hormone (LH) was significantly elevated, and the ratio of testosterone to LH and the ratio of follicle-stimulating hormone (FSH) to LH were decreased considerably [14,15]. This evidence concerns the gene PLOD1 and COVID-19.